FDA Hits Tennessee Drugmaker for Falling Short on Testing

Drug Industry Daily
A A
Multiple violations at Lexia’s Franklin, Tennessee facility netted the drugmaker a Form 483 from the FDA following a March 6-7 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily